Evommune Ownership | Who Owns Evommune?

Evommune Ownership Summary

Evommune is owned by 86.29% institutional investors, and 13.71% retail investors.

EVMN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Evommune	86.29%	-	13.71%
Sector	Healthcare Stocks	232.64%	10.66%	-143.30%
Industry	Biotech Stocks	382.13%	10.41%	-292.54%

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	59	-	27,200,904	-	86	-	59	-	-	-

EVMN Ownership FAQ

Who Owns Evommune?

Evommune shareholders are primarily institutional investors at 86.29%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Evommune's industry, Biotech Stocks , is 382.13%, which Evommune falls below.

Does Blackrock own Evommune?

BlackRock is not among the top 10 institutional shareholders of Evommune.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools